These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 19622553)
1. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Achan J; Tibenderana JK; Kyabayinze D; Wabwire Mangen F; Kamya MR; Dorsey G; D'Alessandro U; Rosenthal PJ; Talisuna AO BMJ; 2009 Jul; 339():b2763. PubMed ID: 19622553 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069 [TBL] [Abstract][Full Text] [Related]
3. AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial. Koita OA; Sangaré L; Miller HD; Sissako A; Coulibaly M; Thompson TA; Fongoro S; Diarra Y; Ba M; Maiga A; Diallo B; Mushatt DM; Mather FJ; Shaffer JG; Anwar AH; Krogstad DJ Lancet Infect Dis; 2017 Dec; 17(12):1266-1275. PubMed ID: 28916443 [TBL] [Abstract][Full Text] [Related]
5. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA; Obonyo CO; Akhwale WS; Ogutu BR Malar J; 2008 Dec; 7():262. PubMed ID: 19102746 [TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
7. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. Yeka A; Tibenderana J; Achan J; D'Alessandro U; Talisuna AO PLoS One; 2013; 8(1):e53772. PubMed ID: 23349741 [TBL] [Abstract][Full Text] [Related]
9. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969 [TBL] [Abstract][Full Text] [Related]
10. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769 [TBL] [Abstract][Full Text] [Related]
11. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064 [TBL] [Abstract][Full Text] [Related]
12. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial. Ursing J; Rombo L; Rodrigues A; Kofoed PE PLoS One; 2016; 11(9):e0161495. PubMed ID: 27649561 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913 [TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial. Obonyo CO; Juma EA; Were VO; Ogutu BR Malar J; 2022 Feb; 21(1):30. PubMed ID: 35109841 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. Wanzira H; Kakuru A; Arinaitwe E; Bigira V; Muhindo MK; Conrad M; Rosenthal PJ; Kamya MR; Tappero JW; Dorsey G Clin Infect Dis; 2014 Aug; 59(4):509-16. PubMed ID: 24825870 [TBL] [Abstract][Full Text] [Related]
18. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series. Sondén K; Wyss K; Jovel I; Vieira da Silva A; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Färnert A Clin Infect Dis; 2017 Jan; 64(2):199-206. PubMed ID: 27986683 [TBL] [Abstract][Full Text] [Related]
19. Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Chandra R; Ansah P; Sagara I; Sie A; Tiono AB; Djimde AA; Zhao Q; Robbins J; Penali LK; Ogutu B Malar J; 2015 Mar; 14():108. PubMed ID: 25881046 [TBL] [Abstract][Full Text] [Related]
20. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Elamin SB; Awad AI; Eltayeb IB; Elmardi KA; Hassan AH; Mohamed AO; Malik EM; Mohamad TA Eur J Clin Pharmacol; 2010 Mar; 66(3):231-7. PubMed ID: 20187287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]